The Resimac Group Ltd (ASX: RMC) share price is in focus after the lender reported an 18% rise in normalised operating profit and a 26% lift in normalised NPAT for FY26.

What did Resimac Group report?

• Normalised operating profit before impairment expense and tax grew 18% to $92.9 million.
• Normalised NPAT rose 26% to $49.9 million; statutory NPAT climbed 42% to $49.2 million.
• Assets under management (AUM) increased 4% to $16.5 billion, with home loans up 10% to $14.7 billion and asset finance up 7% to $1.5 billion.
• Origination volumes rose 16% to $6.7 billion, while application volumes jumped 17% to $10.5 billion.
• Cost to income ratio improved by 60 basis points to 53.0%.
• Fully franked final dividend of 6.0 cents per share, bringing total FY26 dividends (including a special) to 19.0 cents.

What else do investors need to know?

Resimac’s group net interest margin increased 5 basis points to 1.59%, helped by improved funding economics and stronger asset finance margins. The home loan margin remained steady despite a competitive lending environment.

The company’s disciplined management reduced impairment expenses by 5% to $21.4 million, reflecting stable credit quality and improved recoveries. Strategic investments in people and technology supported higher operating income as the Group focused on scalable foundations for long-term growth.

The board declared a fully franked final dividend of 6.0 cents per share, up 2.5 cents on the prior year. Together with the interim and special dividends, the total payout rose 43% year-on-year, reflecting Resimac’s commitment to balanced capital returns and growth.

What did Resimac Group management say?

Pete Lirantzis, Chief Executive Officer, said:

FY26 was a year of stronger earnings, disciplined growth and improved returns. We grew operating profit, expanded margins, maintained strong credit quality and increased shareholder returns while continuing to invest in the foundations of future growth.

What’s next for Resimac Group?

Looking ahead to FY27, Resimac is aiming to cement its position as the ‘Home of Intelligent Lending’ by deepening customer engagement, leveraging technology, and supporting brokers to deliver better outcomes for borrowers.

The company is focused on sustainable home loan growth and higher risk-adjusted returns in asset finance. Management believes recent operational and technology investments will drive resilience, scalability, and long-term value for shareholders.

Resimac Group share price snapshot

Over the past 12 months, Resmiac Group shares have declined 13%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post Resimac Group FY26 earnings: Profit grows and dividends increase appeared first on The Motley Fool Australia.

More reading

• GR Engineering Services completes $100 million placement and share purchase plan
• This small-cap ASX technology stock could more than double in value: Broker
• FireFly Metals share price climbs after $190m raise for Green Bay project
• How many Woolworths shares do I need to earn $10,000 per year in passive income?
• Ainsworth Game Technology posts lower H1 FY26 profit and revenue

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price may be on watch today after the company delivered an 8% increase in revenue to $42.7 million for the half-year ended 30 June 2026, and announced its first ever dividend.

What did Neuren Pharmaceuticals report?

• Revenue rose 8% to $42.7 million (H1 2025: $39.7 million)
• Net profit after tax dropped 68% to $4.9 million (H1 2025: $15.0 million)
• Basic earnings per share was 3.83 cents (H1 2025: 11.88 cents)
• Fully franked interim dividend of 15 cents per share declared
• Royalty income from DAYBUE (trofinetide) up 29% in US dollars to US$23.3 million
• Research and development costs increased to $27.4 million, up $12.5 million

What else do investors need to know?

Neuren’s royalty income is primarily from DAYBUE sales by Acadia Pharmaceuticals, which posted US$226 million net sales in H1 2026, up 25% on last year. Growth was buoyed by the launch of DAYBUE STIX, a new powder formulation, in the US.

The company’s research spend climbed as it advanced its Phase 3 study of NNZ-2591 in Phelan-McDermid syndrome. Neuren also implemented an on-market share buy-back, repurchasing $3.9 million in shares.

Importantly for shareholders, Neuren’s new dividend policy has resulted in a fully franked interim dividend, to be paid in October. This marks the company’s first ever payout and reflects its confidence in ongoing royalty streams.

What did Neuren Pharmaceuticals management say?

Neuren’s CEO, Jonathan Pilcher, commented:

Neuren’s substantial income from trofinetide means that we are in the enviable position of being able to fund all development programs for NNZ-2591 aiming for significant capital appreciation, as well as optimise total shareholder return through ongoing fully franked dividends.

What’s next for Neuren Pharmaceuticals?

Looking ahead, Neuren expects continued growth in global DAYBUE sales, with Acadia guiding for 2026 net sales of US$480–510 million. The first commercial launch in Europe is targeted for Q4 2026, following a positive opinion from the European Medicines Agency.

Neuren will also focus on progressing its NNZ-2591 clinical programs, with key FDA meetings scheduled and trial sites ramping up for rare neurodevelopmental disorders. Management aims to leverage these investments into further royalty income and milestone payments.

Neuren Pharmaceuticals share price snapshot

The Neuren Pharmaceuticals share price has outperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a gain of over 25%.

View Original Announcement

The post Neuren Pharmaceuticals reports lower profit but launches first dividend appeared first on The Motley Fool Australia.

More reading

• Neuren share price in focus after DAYBU wins EU approval for Rett syndrome
• Here are the top 10 ASX 200 shares today
• 3 ASX 200 stocks storming higher this week on big news
• 5 ASX 200 broker buy ratings
• Are Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The COG Financial Services Ltd (ASX: COG) share price is in focus after reporting a 28% lift in EBITDA attributable to shareholders to $51.5 million for FY26, with earnings per share up 27% and a higher final dividend declared.

What did COG Financial Services report?

• EBITDA to shareholders of $51.5 million, up 28% on FY25
• Earnings per share (EPSA) of 15.63 cents, up 27% year on year
• Fully franked final dividend of 3.5 cents per share, up 17%
• Net Assets Financed lifted 8% to $9.0 billion
• Salary packaging customer numbers surged 31% to 68,510
• Novated lease customers up 98% to 22,281

What else do investors need to know?

COG made strategic moves in FY26, acquiring 100% of Easifleet Pty Ltd and lifting its stake in Fleet Network Pty Ltd through subsidiaries. These investments have supported strong customer growth, particularly across the salary packaging and novated leasing lines, with demand bolstered by government electric vehicle incentives.

The Group’s Broking & Aggregation business remained stable, and management noted continued focus on investing in digital platforms to enhance customer experience. COG also maintained its dividend reinvestment plan suspension for the final dividend.

What did COG Financial Services management say?

Chief Executive Officer Andrew Bennett said:

COG’s underlying EBITDA to shareholders grew 28% on the prior year, driven by strong organic growth and disciplined acquisitions. Salary Packaging led the way with 51% revenue growth, thanks to volume gains and a recent acquisition, while the rest of the Group performed solidly despite continued investment in people and systems. These results show the strength of our diversified business and our disciplined approach to growth.

What’s next for COG Financial Services?

Looking ahead, COG targets EBITDA growth of 10% or better in FY27, banking on continued strong results in salary packaging as electric vehicle adoption rises. Management is also backing technology and AI investments to further streamline operations and grow the business.

COG aims to expand its Broking & Aggregation services, reduce client churn, and pursue bolt-on acquisitions if the right opportunities arise. The company also expects further geographic expansion from its Equity-One unit.

COG Financial Services share price snapshot

Over the past 12 months, COG Financial Services shares have declined 18%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post COG Financial Services lifts profit 28% and grows dividend for FY26 appeared first on The Motley Fool Australia.

More reading

• GR Engineering Services completes $100 million placement and share purchase plan
• This small-cap ASX technology stock could more than double in value: Broker
• FireFly Metals share price climbs after $190m raise for Green Bay project
• How many Woolworths shares do I need to earn $10,000 per year in passive income?
• Ainsworth Game Technology posts lower H1 FY26 profit and revenue

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.